Sjs Investment Consulting Inc. Myriad Genetics Inc Transaction History
Sjs Investment Consulting Inc.
- $499 Million
- Q2 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Myriad Genetics Inc stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 13 shares of MYGN stock, worth $359. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 13
-0.0%
Holding current value
$359
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MYGN
# of Institutions
197Shares Held
94.2MCall Options Held
280KPut Options Held
14.3K-
Black Rock Inc. New York, NY14.9MShares$411 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$277 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.06MShares$223 Million0.03% of portfolio
-
Camber Capital Management LP Boston, MA7.64MShares$211 Million3.99% of portfolio
-
State Street Corp Boston, MA5.4MShares$149 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $2.23B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...